Your browser doesn't support javascript.
loading
Dysbiosis of fecal microbiota and high frequency of citrobacter, klebsiella spp., and actinomycetes in patients with irritable bowel syndrome and gastroenteritis
Gastroenterology and Hepatology from Bed to Bench. 2016; 9 (4): 325-330
em En | IMEMR | ID: emr-184694
Biblioteca responsável: EMRO
Aim: This study was aimed to characterize putative differences of fecal microbiota between irritable bowel syndrome[IBS] and gastroenteritis patients and healthy controls
Background: New evidence proposed that gut microbiota has a deep effect on the balance between health and disease
Patients and methods: The presence of Clostridium difficile, Campylobacter spp., Enterobacteriacea and Staphylococci weredetected in the samples using selective and specific culture media. Microscopic examination of the samples was done to detectActinomycetes, yeasts, Bifidobacteria, Fusobacterium spp., as well as white blood cells, red blood cells, mucus and epithelial cells
Results: Results of this study showed relatively higher frequency of Citrobacter spp., Lactobacilli, and Actinomycetes in theIBS patients. Elevated levels of WBC, RBC secretion, and increased amounts of Klebsiella, Escherichia coli and Citrobacterspp. were characterized in the patients with gastroenteritis compared with the control group
Conclusion: Depletion of gram positive cocci and gram negative bacilli also suggested dysbiosis of intestinal microbiotain these patients
Buscar no Google
Índice: IMEMR Idioma: En Revista: Gastroenterol. Hepatol. Bed Bench Ano de publicação: 2016
Buscar no Google
Índice: IMEMR Idioma: En Revista: Gastroenterol. Hepatol. Bed Bench Ano de publicação: 2016